Mr Tom Wright
- Research Assistant (Therapeutic Science Research)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Cooke, S. F. et al. (2025) Targeting MDM2 homodimer and heterodimer disruption with DRx-098D in TP53 wild-type and mutant cancer cells. Molecular Therapy Oncology, 33(3), 201029. (doi: 10.1016/j.omton.2025.201029) (PMID:40896364) (PMCID:PMC12395054)
Main, Alice, Mary, Sheon ORCID: https://orcid.org/0000-0001-9392-3020, Sin, Yuan Yan
ORCID: https://orcid.org/0000-0001-6537-5266, Wright, Tom A., Ling, Jiayue, Blair, Connor M., Smith, Godfrey L.
ORCID: https://orcid.org/0000-0003-4821-9741, Fuller, Will
ORCID: https://orcid.org/0000-0002-5883-4433 and Baillie, George S.
ORCID: https://orcid.org/0000-0003-2469-6316
(2024)
SUMOylation of cardiac myosin binding protein-C reduces its phosphorylation and results in impaired relaxation following treatment with isoprenaline.
International Journal of Biochemistry and Cell Biology, 176,
106668.
(doi: 10.1016/j.biocel.2024.106668)
(PMID:39321569)
Thongyim, Saruda, Wright, Thomas A., Sattayawat, Pachara, Kaewkod, Thida, Baillie, George S. ORCID: https://orcid.org/0000-0003-2469-6316, Tragoolpua, Yingmanee, Jangsutthivorawat, Siriphorn and Panya, Aussara
(2024)
Clinacanthus nutans extract lowers periodontal inflammation under high-glucose conditions via inhibiting NF-κB signaling pathway.
Frontiers in Pharmacology, 15,
1410419.
(doi: 10.3389/fphar.2024.1410419)
Sin, Y. Y. et al. (2024) Beta-amyloid interacts with and activates the longform phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability. FEBS Letters, 598(13), pp. 1591-1604. (doi: 10.1002/1873-3468.14902) (PMID:38724485)
Cooke, S. F. et al. (2024) Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC. Scientific Reports, 14, 8998. (doi: 10.1038/s41598-024-59451-3) (PMID:38637546) (PMCID:PMC11026450)
Wright, Thomas A., Gemmell, Alistair O., Tejeda, Gonzalo S. ORCID: https://orcid.org/0000-0002-2900-6276, Blair, Connor M. and Baillie, George S.
ORCID: https://orcid.org/0000-0003-2469-6316
(2023)
Cancer: phosphodiesterase type 4C (PDE4C), the forgotten subfamily as a therapeutic target.
International Journal of Biochemistry and Cell Biology, 162,
106453.
(doi: 10.1016/j.biocel.2023.106453)
(PMID:37499270)
Cooke, S. F. et al. (2025) Targeting MDM2 homodimer and heterodimer disruption with DRx-098D in TP53 wild-type and mutant cancer cells. Molecular Therapy Oncology, 33(3), 201029. (doi: 10.1016/j.omton.2025.201029) (PMID:40896364) (PMCID:PMC12395054)
Main, Alice, Mary, Sheon ORCID: https://orcid.org/0000-0001-9392-3020, Sin, Yuan Yan
ORCID: https://orcid.org/0000-0001-6537-5266, Wright, Tom A., Ling, Jiayue, Blair, Connor M., Smith, Godfrey L.
ORCID: https://orcid.org/0000-0003-4821-9741, Fuller, Will
ORCID: https://orcid.org/0000-0002-5883-4433 and Baillie, George S.
ORCID: https://orcid.org/0000-0003-2469-6316
(2024)
SUMOylation of cardiac myosin binding protein-C reduces its phosphorylation and results in impaired relaxation following treatment with isoprenaline.
International Journal of Biochemistry and Cell Biology, 176,
106668.
(doi: 10.1016/j.biocel.2024.106668)
(PMID:39321569)
Thongyim, Saruda, Wright, Thomas A., Sattayawat, Pachara, Kaewkod, Thida, Baillie, George S. ORCID: https://orcid.org/0000-0003-2469-6316, Tragoolpua, Yingmanee, Jangsutthivorawat, Siriphorn and Panya, Aussara
(2024)
Clinacanthus nutans extract lowers periodontal inflammation under high-glucose conditions via inhibiting NF-κB signaling pathway.
Frontiers in Pharmacology, 15,
1410419.
(doi: 10.3389/fphar.2024.1410419)
Sin, Y. Y. et al. (2024) Beta-amyloid interacts with and activates the longform phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability. FEBS Letters, 598(13), pp. 1591-1604. (doi: 10.1002/1873-3468.14902) (PMID:38724485)
Cooke, S. F. et al. (2024) Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC. Scientific Reports, 14, 8998. (doi: 10.1038/s41598-024-59451-3) (PMID:38637546) (PMCID:PMC11026450)
Wright, Thomas A., Gemmell, Alistair O., Tejeda, Gonzalo S. ORCID: https://orcid.org/0000-0002-2900-6276, Blair, Connor M. and Baillie, George S.
ORCID: https://orcid.org/0000-0003-2469-6316
(2023)
Cancer: phosphodiesterase type 4C (PDE4C), the forgotten subfamily as a therapeutic target.
International Journal of Biochemistry and Cell Biology, 162,
106453.
(doi: 10.1016/j.biocel.2023.106453)
(PMID:37499270)